SHANGHAI, April 19, 2024 /PRNewswire/ — GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in…

NEW YORK, April 19, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ: QDEL). Shareholders who purchased shares of QDEL during the class period listed are encouraged to contact the firm regarding…

NEW YORK, April 19, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of VinFast Auto Ltd. f/k/a Black Spade Acquisition Co. (NASDAQ: VFS). Shareholders who purchased shares of VFS during the class period listed are encouraged to contact the firm…

SHANGHAI, April 19, 2024 /PRNewswire/ — Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) (“Baozun,” the “Company” or the “Group”), a leading brand e-commerce solution provider and digital commerce enabler in China, today announced the appointment of Ms. Catherine Zhu as Chief Financial Officer,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.